Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

BMS Reverse Cholesterol Transport (RCT) Study
A Pilot Study to Evaluate the Use of 3H Particulate Cholesterol as a Method to Study Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
BMS Reverse Cholesterol Transport (RCT) Study
A Pilot Study to Evaluate the Use of 3H Particulate Cholesterol as a Method to Study Reverse Cholesterol Transport in Humans
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of the Safety of USB005 in Healthy Volunteers
Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study
Status: Enrolling
Updated:  12/31/1969
mi
from
Cypress, CA
Study of the Safety of USB005 in Healthy Volunteers
Evaluation of USB005 in a Phase 1 Normal, Healthy Volunteer Ocular Safety and PK Study
Status: Enrolling
Updated: 12/31/1969
Wcct Global, Llc
mi
from
Cypress, CA
Click here to add this to my saved trials
Study of LY3154207 in Healthy Participants
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Madison, WI
Study of LY3154207 in Healthy Participants
Disposition of [14C]-LY3154207 Following Oral Administration in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Inc
mi
from
Madison, WI
Click here to add this to my saved trials
Determination of Normal Reference Values of CRP, Procalcitonin, and Lactate Levels for the Nanōmix eLab® System
Evaluation of the Levels of C-Reactive Protein, Procalcitonin, and Lactate in a Normal Healthy Population When Tested With the Nanōmix eLab® System
Status: Enrolling
Updated:  12/31/1969
mi
from
San Francisco, CA
Determination of Normal Reference Values of CRP, Procalcitonin, and Lactate Levels for the Nanōmix eLab® System
Evaluation of the Levels of C-Reactive Protein, Procalcitonin, and Lactate in a Normal Healthy Population When Tested With the Nanōmix eLab® System
Status: Enrolling
Updated: 12/31/1969
Zuckerberg San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PHP-303 in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Overland Park, KA
A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects
A Phase 1, Single-Center, Randomized, Double-Blind, Placebo-Controlled Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PHP-303 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20
A Phase I, Randomized, Dose-Ranging, Pharmacokinetic, Glucodynamic, Safety, and Tolerability Study of SC Administered Humulin R and Humalog With or Without Recombinant Human Hyaluronidase (rHuPH20) in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20
A Phase I, Randomized, Dose-Ranging, Pharmacokinetic, Glucodynamic, Safety, and Tolerability Study of SC Administered Humulin R and Humalog With or Without Recombinant Human Hyaluronidase (rHuPH20) in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
dgd Research, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase I Study of SB26 in Healthy Volunteers
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Glendale, CA
A Phase I Study of SB26 in Healthy Volunteers
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Rising Dose Study to Explore the Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of SB26 in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Parexel International
mi
from
Glendale, CA
Click here to add this to my saved trials
Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat
A 2-Stage, Open-Label, Randomized, Single-Dose, Crossover Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Lincoln, NE
Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat
A 2-Stage, Open-Label, Randomized, Single-Dose, Crossover Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
Implant Pharmacokinetic and Pharmacodynamic Study
A Phase Ib Study to Confirm the Pharmacokinetics and Melanogenic Potential of Controlled-Release Bioresorbable Implants of Afamelanotide in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Paul, MN
Implant Pharmacokinetic and Pharmacodynamic Study
A Phase Ib Study to Confirm the Pharmacokinetics and Melanogenic Potential of Controlled-Release Bioresorbable Implants of Afamelanotide in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects
A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of PBI-4050 on the Pharmacokinetics of Midazolam, a Sensitive Cytochrome P450 3A Substrate, in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Tempe, AZ
Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects
A Phase 1, Drug-Drug Interaction Study to Evaluate the Effect of PBI-4050 on the Pharmacokinetics of Midazolam, a Sensitive Cytochrome P450 3A Substrate, in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Increasing Water Access and Appeal in Community Recreation Centers
A Randomized Trial of a Comprehensive Multi-level Intervention to Increase Water Access and Appeal in Community Recreation Centers
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
Increasing Water Access and Appeal in Community Recreation Centers
A Randomized Trial of a Comprehensive Multi-level Intervention to Increase Water Access and Appeal in Community Recreation Centers
Status: Enrolling
Updated: 12/31/1969
Philadelphia Department of Public Health, Division of Chronic Disease Prevention
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Malaria: Relative Bioavailability and Food Effect of DSM265
Relative Bioavailability and Effect of Food on DSM265-TPGS 34% SDD Powder in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Grayslake, IL
Malaria: Relative Bioavailability and Food Effect of DSM265
Relative Bioavailability and Effect of Food on DSM265-TPGS 34% SDD Powder in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
AbbVie Clinical Pharmacology Research Unit (ACPRU)
mi
from
Grayslake, IL
Click here to add this to my saved trials
Cconsumer Perspective and Understanding of the Term "Milk"
A Pilot Study Investigating Consumer Perspective and Understanding of the Term "Milk"
Status: Enrolling
Updated:  12/31/1969
mi
from
Chicago, IL
Cconsumer Perspective and Understanding of the Term "Milk"
A Pilot Study Investigating Consumer Perspective and Understanding of the Term "Milk"
Status: Enrolling
Updated: 12/31/1969
Clinical Nutrition Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults
A Randomized, Open-Label, Single-Dose, Two-Period Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Formulations of Vadadustat 150 mg Tablets
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults
A Randomized, Open-Label, Single-Dose, Two-Period Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Formulations of Vadadustat 150 mg Tablets
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Comparison of High-intensity Interval Training Protocols on Health and Fitness
A Comparison of High-intensity Interval Training Protocols on Cardiometabolic Markers, Physical Performance, and Psychosocial Markers in College Females
Status: Enrolling
Updated:  12/31/1969
mi
from
Rochester, MI
A Comparison of High-intensity Interval Training Protocols on Health and Fitness
A Comparison of High-intensity Interval Training Protocols on Cardiometabolic Markers, Physical Performance, and Psychosocial Markers in College Females
Status: Enrolling
Updated: 12/31/1969
Oakland University
mi
from
Rochester, MI
Click here to add this to my saved trials
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C] ASN002 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Madison, WI
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C] ASN002 Following a Single Oral Dose in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of SYNT001 in Healthy Volunteers
A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami, FL
A Study of SYNT001 in Healthy Volunteers
A Phase 1a, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of SYNT001 in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence
Performance of the ID-Cap System, in the Clinical Setting as an Aid to Measure Medication Adherence (DO Trial 2.0)
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami, FL
Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence
Performance of the ID-Cap System, in the Clinical Setting as an Aid to Measure Medication Adherence (DO Trial 2.0)
Status: Enrolling
Updated: 12/31/1969
Quotient Sciences
mi
from
Miami, FL
Click here to add this to my saved trials
Study of CVN424 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CVN424 in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Study of CVN424 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Escalating Single and Multiple Doses of CVN424 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
PPD Development, LP
mi
from
Austin, TX
Click here to add this to my saved trials
A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet
A Randomized, Open-Label, Single-Dose, Three-Period Six-Sequence Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Vadadustat 450 mg and 150 mg Tablets and to Determine Food Effect on the 450 mg Vadadustat Tablet.
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet
A Randomized, Open-Label, Single-Dose, Three-Period Six-Sequence Crossover Study in Healthy Adults to Assess Bioequivalence Between Test and Reference Vadadustat 450 mg and 150 mg Tablets and to Determine Food Effect on the 450 mg Vadadustat Tablet.
Status: Enrolling
Updated: 12/31/1969
PARAXEL International
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Nephure™, and the Reduction of Dietary Oxalate, in Healthy Volunteers
A Prospective, Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study With Nephure™, an Orally Administered Oxalate Reducing Enzyme
Status: Enrolling
Updated:  12/31/1969
mi
from
Springfield, MO
Evaluation of Nephure™, and the Reduction of Dietary Oxalate, in Healthy Volunteers
A Prospective, Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study With Nephure™, an Orally Administered Oxalate Reducing Enzyme
Status: Enrolling
Updated: 12/31/1969
QPS Bio-Kinetic Clinical Applications
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study of Two Formulations of LY3074828 in Healthy Participants
A Safety, Tolerability, and Pharmacokinetic Study of Injections of LY3074828 Solution Using Investigational 1-mL Pre-filled Syringes and Investigational 2-mL Autoinjector in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Daytona Beach, FL
A Study of Two Formulations of LY3074828 in Healthy Participants
A Safety, Tolerability, and Pharmacokinetic Study of Injections of LY3074828 Solution Using Investigational 1-mL Pre-filled Syringes and Investigational 2-mL Autoinjector in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Inc
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
PPD, Phase 1 Clinic
mi
from
Austin, TX
Click here to add this to my saved trials
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites
A Phase 1, Multi-center, Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active Metabolites in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
ICON Early Phase Services
mi
from
San Antonio, TX
Click here to add this to my saved trials
Smart Sleep In-home Validation Extension Study
Smart Sleep In-home Validation Extension Study
Status: Enrolling
Updated:  12/31/1969
mi
from
Lehigh Acres, FL
Smart Sleep In-home Validation Extension Study
Smart Sleep In-home Validation Extension Study
Status: Enrolling
Updated: 12/31/1969
Florida Lung & Sleep Associates
mi
from
Lehigh Acres, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
A Phase 1 Open-Label Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 (Dendrimer N-Acetyl-Cysteine) After Intravenous Administration in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
A Phase 1 Open-Label Single-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 (Dendrimer N-Acetyl-Cysteine) After Intravenous Administration in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
The INcreased Flow Utilizing Subcutaneously-Enabled Normal Saline and Lactated Ringer's (INFUSE-NSLR) Study: A Phase IV, Double-Blind, Randomized Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex) in Volunteer Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Kalamazoo, MI
Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
The INcreased Flow Utilizing Subcutaneously-Enabled Normal Saline and Lactated Ringer's (INFUSE-NSLR) Study: A Phase IV, Double-Blind, Randomized Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex) in Volunteer Subjects
Status: Enrolling
Updated: 12/31/1969
Jasper Clinic, Inc.
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants
A Phase 1 Bioavailability and Food Effect Study to Compare Tablet Versus Solution Formulation and to Assess the Effect of Food on the Bioavailability of a Single TAK-935 Dose in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Glendale, CA
A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants
A Phase 1 Bioavailability and Food Effect Study to Compare Tablet Versus Solution Formulation and to Assess the Effect of Food on the Bioavailability of a Single TAK-935 Dose in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Status: Enrolling
Updated:  12/31/1969
mi
from
National City, CA
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
Status: Enrolling
Updated: 12/31/1969
Medical Office of Mohammad T. Bailony
mi
from
National City, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
A Phase 1 Combined Single and Multiple Ascending Oral Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MA-0211 in Healthy Adult Subjects Including a Food Effect Cohort
Status: Enrolling
Updated: 12/31/1969
Parexel Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
mi
from
Irvine, CA
Masimo Clinical Lab
mi
from
Irvine, CA
Click here to add this to my saved trials
Accuracy of Acoustic Rainbow Monitoring (ARM) Sensor
Status: Enrolling
Updated:  12/31/1969
mi
from
Irvine, CA
Accuracy of Acoustic Rainbow Monitoring (ARM) Sensor
Status: Enrolling
Updated: 12/31/1969
Masimo Clinical Lab
mi
from
Irvine, CA
Click here to add this to my saved trials
Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote
A Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered PRT064445, a Factor Xa (fXa) Inhibitor Antidote
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote
A Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered PRT064445, a Factor Xa (fXa) Inhibitor Antidote
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Postprandial Glycemia in Orange Products
Effect of Added Fruit Pomace Fiber and Whole Fruit on Postprandial Glycemia in Orange
Status: Enrolling
Updated:  12/31/1969
mi
from
Chicago, IL
Postprandial Glycemia in Orange Products
Effect of Added Fruit Pomace Fiber and Whole Fruit on Postprandial Glycemia in Orange
Status: Enrolling
Updated: 12/31/1969
Clinical Nutrition Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses
Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of BLI-489 Administered Intravenously to Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Tacoma, WA
Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses
Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of BLI-489 Administered Intravenously to Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
An Open-Label Study To Evaluate D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562, Using Positron Emission Tomography (PET) With Ligand [18F]MNI-968 in Healthy Male Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
New Haven, CT
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
An Open-Label Study To Evaluate D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562, Using Positron Emission Tomography (PET) With Ligand [18F]MNI-968 in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Invicro
mi
from
New Haven, CT
Click here to add this to my saved trials
Effect of Venglustat in Patients With Renal Impairment
A Phase I, Single-Center, Open-label, Single Dose Pharmacokinetic and Tolerability Study of GZ402671 in Subjects With Mild, Moderate and Severe Renal Impairment, and in Matched Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami, FL
Effect of Venglustat in Patients With Renal Impairment
A Phase I, Single-Center, Open-label, Single Dose Pharmacokinetic and Tolerability Study of GZ402671 in Subjects With Mild, Moderate and Severe Renal Impairment, and in Matched Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone
An Open-Label, Single-Dose, Randomized, Three-Way Crossover Study in Healthy Volunteers to Estimate the Effects of Food and of Sprinkling ALO-02 Pellets on Applesauce on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Pellets-in-Capsule Formulation of Oxycodone 40 Mg With Sequestered Naltrexone 4.8 Mg
Status: Enrolling
Updated:  12/31/1969
mi
from
New Haven, CT
Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone
An Open-Label, Single-Dose, Randomized, Three-Way Crossover Study in Healthy Volunteers to Estimate the Effects of Food and of Sprinkling ALO-02 Pellets on Applesauce on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Pellets-in-Capsule Formulation of Oxycodone 40 Mg With Sequestered Naltrexone 4.8 Mg
Status: Enrolling
Updated: 12/31/1969
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Effect of Copanlisib on Metformin PK and PD
An Open-label, Non-randomized, Phase I Study to Evaluate the Effect of Copanlisib (a Single Intravenous Dose of 60 mg) on the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Metformin (MATE2-K Substrate) in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Effect of Copanlisib on Metformin PK and PD
An Open-label, Non-randomized, Phase I Study to Evaluate the Effect of Copanlisib (a Single Intravenous Dose of 60 mg) on the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Metformin (MATE2-K Substrate) in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Pharmaceutical Product Development, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of LY2484595 in Healthy Subjects
Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Glendale, CA
A Study of LY2484595 in Healthy Subjects
Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of Evacetrapib in Healthy Participants
Effect of Gemfibrozil on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
Daytona Beach, FL
A Study of Evacetrapib in Healthy Participants
Effect of Gemfibrozil on the Pharmacokinetics of Evacetrapib (LY2484595) in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
Single-Dose, Randomized, Open-Label, 4-Period, 4-Sequence Crossover Study of Three Prototypes of K-877 CR Tablet and Two K-877 Tablets Administered to Healthy Adult Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
Single-Dose, Randomized, Open-Label, 4-Period, 4-Sequence Crossover Study of Three Prototypes of K-877 CR Tablet and Two K-877 Tablets Administered to Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
PPD Development, LP
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
A Phase I, Open-label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion and to Assess the Absolute Bioavailability of AG-348 in Healthy Male Subjects Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
Status: Enrolling
Updated:  12/31/1969
mi
from
Madison, WI
A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
A Phase I, Open-label Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion and to Assess the Absolute Bioavailability of AG-348 in Healthy Male Subjects Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348
Status: Enrolling
Updated: 12/31/1969
Covance, Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
Effects Of Ingesting An Energy Bar On Performance And Recovery
Effects Of Ingesting A Low Glycemic Whey Protein Energy Bar Prior, During And Following Resistance Exercise And Conditioning On Performance And Recovery
Status: Enrolling
Updated:  12/31/1969
mi
from
College Station, TX
Effects Of Ingesting An Energy Bar On Performance And Recovery
Effects Of Ingesting A Low Glycemic Whey Protein Energy Bar Prior, During And Following Resistance Exercise And Conditioning On Performance And Recovery
Status: Enrolling
Updated: 12/31/1969
Exercise & Sport Nutrition Lab - Human Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
A Phase 1, Open-Label, Randomized, Parallel Dose Group Study to Assess the Pharmacokinetics of Mirabegron OCAS Formulations With Different Release Rates Versus IV Infusion in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Tacoma, WA
Pharmacokinetics of Oral Mirabegron With Different Release Rates Versus Intravenous (IV) Mirabegron
A Phase 1, Open-Label, Randomized, Parallel Dose Group Study to Assess the Pharmacokinetics of Mirabegron OCAS Formulations With Different Release Rates Versus IV Infusion in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Status: Enrolling
Updated:  12/31/1969
mi
from
Madison, WI
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin-Madison Natatorium
mi
from
Madison, WI
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
A Double-Blind, Placebo-Controlled, 2-Part, Single Ascending Dose and Multiple Dose Cohort Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
A Double-Blind, Placebo-Controlled, 2-Part, Single Ascending Dose and Multiple Dose Cohort Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Worldwide Clinical Trials
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
A Phase I, Open-label, Randomized, 4-period Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of K-285 Compared With a Single Oral Dose of Indomethacin Capsule in Healthy Adult Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
A Phase I, Open-label, Randomized, 4-period Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of K-285 Compared With a Single Oral Dose of Indomethacin Capsule in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
PPD Development, LP
mi
from
Austin, TX
Click here to add this to my saved trials
The Effects of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid on Healthy Male Subjects
Exploratory Study to Determine the Bioavailability and Metabolism of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid
Status: Enrolling
Updated:  12/31/1969
mi
from
Los Angeles, CA
The Effects of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid on Healthy Male Subjects
Exploratory Study to Determine the Bioavailability and Metabolism of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid
Status: Enrolling
Updated: 12/31/1969
UCLA Center for Human Nutrition, 900 Veteran Ave.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Drug Interaction Study of CT1812 in Healthy Volunteers
A Fixed-Sequence Trial to Examine the Effect of Multiple-Dose CT1812 Administration on Standard Probes of CYP2C19 (Omeprazole), CYP2C9 (Tolbutamide), CYP2D6 (Dextromethorphan), and CYP3A4/5 (Midazolam) Activity in Healthy Adult Volunteers
Status: Enrolling
Updated:  12/31/1969
mi
from
Kalamazoo, MI
Drug Interaction Study of CT1812 in Healthy Volunteers
A Fixed-Sequence Trial to Examine the Effect of Multiple-Dose CT1812 Administration on Standard Probes of CYP2C19 (Omeprazole), CYP2C9 (Tolbutamide), CYP2D6 (Dextromethorphan), and CYP3A4/5 (Midazolam) Activity in Healthy Adult Volunteers
Status: Enrolling
Updated: 12/31/1969
Jasper Clinic, Inc.
mi
from
Kalamazoo, MI
Click here to add this to my saved trials